Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective
Mei Ding1, Roger Clark2, Catherine Bardelle3
11 Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Abstract:
Flow cytometry is a powerful tool providing multiparametric analysis of single cells or particles. The introduction of faster plate-based sampling technologies on flow cytometers has transformed the technology into one that has become attractive for higher throughput drug discovery screening. This article describes AstraZeneca's perspectives on the deployment and application of high-throughput flow cytometry (HTFC) platforms for small-molecule high-throughput screening (HTS), structure-activity relationship (SAR) and phenotypic screening, and antibody screening. We describe the overarching HTFC workflow, including the associated automation and data analysis, along with a high-level overview of our HTFC assay portfolio. We go on to discuss the practical challenges encountered and solutions adopted in the course of our deployment of HTFC, as well as future enhancements and expansion of the technology to new areas of drug discovery.
More Related Videos
09:11Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
Published on: January 27, 2023
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Related Concept Videos
Drug Discovery: Overview
Flow Cytometry
In...
Applications of Integration to Find Blood Flow
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
The pKa of a...
Social Cognitive Perspective on Personality